聚[2-(甲基丙烯酰氧)乙基三甲基氯化铵]/阿拉伯胶复凝聚法十二醇微胶囊的制备

将聚[2-(甲基丙烯酰氧)乙基三甲基氯化铵](PMTC)和阿拉伯胶(GA)在一定条件下进行了复凝聚,并对影响复凝聚实验的壁材配比、壁材浓度、离子强度等因素进行了考察.实验结果表明,PMTC与GA配比为1/3.22,壁材总浓度为4%时复凝聚效率最高;体系中不同浓度的氯化钠的存在会对复凝聚起到不同程度的抑制作用.在实验确定的最佳复凝聚条件下以有机小分子化合物十二醇作为芯材进行了包覆,制备了不同壁芯比例的微胶囊.对微胶囊的包覆率及载药量进行了测量,并对它们的释放行为进行了考察.包覆有十二醇的复合微胶囊大小一般在几微米.随着壁材与芯材比例的增大,胶囊载药量逐渐降低,微胶囊释放十二醇的速率明显变小,但包覆率却无明显变化规律.     

复凝聚法制备昆虫激素模拟物十二醇微胶囊及其释放性能

以明胶(GE)和阿拉伯胶(AG)为壁材, 通过复凝聚法将昆虫激素模拟物十二醇(C12OH)包覆在微胶囊中, 改变微胶囊壁材的浓度和交联度, 探讨了体系中C12OH的可控释放性能. 通过对壁材质量比为1及不同pH条件下的壁材凝聚率测试确定最佳复凝聚的pH为4.0; 考察了不同分散剂对微胶囊及其分散液性能的影响, 确定以Tween 20/Span 80(质量比1∶1)作为复凝聚法包覆C12OH体系的分散剂. 在壁材质量分数大于或等于3%条件下制备的微胶囊粒径大于壁材质量分数为2%的微胶囊, 胶囊的载药量和C12OH包覆率明显高于后者. 增加交联剂的用量, 壁材交联度、胶囊的载药量和C12OH包覆率都显著提高. 在相同用量的情况下, 用甲醛作交联剂时得到的微胶囊的交联度比用戊二醛作交联剂时的要低, 但其对C12OH的包覆率更高. 通过扫描电镜对微胶囊进行了分析, 认为GE与AG通过复凝聚能够将C12OH包覆在微胶囊内部. 对胶囊中C12OH在恒温恒湿条件下的释放研究结果表明, 3%与4%壁材含量下1%戊二醛交联的微胶囊和5%壁材含量下4%戊二醛交联的微胶囊中C12OH的释放行为有明显的可控性. 通过调节微胶囊的壁材含量和交联度可以达到昆虫激素可控释放的目的.     

昆虫激素模拟化合物十二醇微胶囊的制备与释放行为研究

利用昆虫雌性激素对昆虫进行干扰交配是近年来使用的一种新技术,可替代农药杀虫剂达到高选择性无毒无药灭害的目的.鉴于十二醇(C12H25OH)与简单的昆虫激素化合物十二碳烯醇、十二碳烯二醇等结构相近,使用C12H25OH作为昆虫激素的模拟物,探索使用聚合物微球水分散体系将昆虫激素模拟物C12H25OH包覆在聚合物微球中,通过改变水分散体系的制备方法、复合微球壁的交联度等探讨了此类体系对C12H25OH的可控释放.首先通过测定阿拉伯胶明胶复凝聚过程的透光率、ζ电位,确定了阿拉伯胶-明胶的质量配比为1时可达最大复凝聚.在此基础上,制备了一系列交联剂戊二醛含量不同的复合微胶囊.结果表明微胶囊壁材的交联度随交联剂量明显上升,其对C12H25OH的包覆率经1%戊二醛交联后即提高至未交联体系的约三倍.但进一步提高戊二醛的含量,虽然胶囊的交联度仍明显上升,但对C12H25OH的包覆率基本保持恒定.使用同样量的甲醛可达同样交联效果,但对C12H25OH的包覆率有明显提高.在恒温恒湿条件下对各胶囊的C12H25OH释放行为进行了表征,结果显示交联胶囊可明显提高C12H25OH的恒速释放时间,交联度越高,恒速释放越稳定.本工作表明通过本方法确实可以达到将昆虫激素包覆在聚合物颗粒中并达到可控释放.     

昆虫激素十二醇微胶囊的制备与释放行为研究

利用昆虫雌性激素对昆虫进行干扰交配是近年来使用的一种新技术,可替代农药杀虫剂达到高选择性无毒无药灭害的目的。迄今为止的相关研究及应用技术都是使用载有昆虫激素的棉条、纸片、塑胶管等装置,以一定密度置于果园或农田。十二醇是较为简单的一个存在于多种昆虫的雌性激素中化合物。本文首次探索使用聚合物微球水分散体系将昆虫激素十二醇(C12OH)包覆在聚合物微球中,通过改变水分散体系的制备方法、复合微球壁的交联度等探讨了此类体系对C12OH的可控释放。本工作首先通过测定阿拉伯胶明胶复凝聚过程的透光率、ζ电位,确定了阿拉伯胶-明胶的重量配比为1时可达最大复凝聚。在此基础上,制备了一系列不同交联剂戊二醛含量的复合微胶囊。结果表明微胶囊壁材的交联度随交联剂量明显上升,其对C12OH的包覆率经1%戊二醛交联后即提高至未交联体系的约三倍。但进一步提高戊二醛的含量,虽然胶囊的交联度仍明显上升,但对C12OH的包覆率基本保持恒定。使用同样量的甲醛可达同样交联效果,但对C12OH的包覆率有明显提高。在恒温恒湿条件下对各胶囊的C12OH释放行为进行了表征,结果显示交联胶囊可明显提高C12OH的恒速释放时间,交联度越高,恒速释放越稳定。本工作表明通过本方法确实可以达到将昆虫激素包覆在聚合物颗粒中并达到可控释放。     

乳清蛋白/阿拉伯胶复凝聚法制备载乙酸油酯微胶囊及其表征

油醇(十八烯醇)与乙酸酐的摩尔比为1/1.7,催化剂对甲苯磺酸用量为油醇与乙酸酐总质量的0.2%,25℃反应3h合成了昆虫性激素成分之一的乙酸油酯并对其进行了表征.以高分子电解质乳清蛋白(WP)和阿拉伯胶(GA)进行复凝聚制备聚合物微胶囊,对影响复凝聚的pH、两种电解质的配比及其浓度等因素进行了考察.结果表明在pH=3.5,WP/GA质量比1.5,WP和GA总浓度1.0%时复凝聚效果最佳.在该条件下以WP/GA为壁材对乙酸油酯进行了包覆,制备了不同壁材总浓度的载油微胶囊,对微胶囊的载油量和包覆率进行了测量.随着壁材总浓度的增大,芯材乙酸油酯包覆率呈现先上升后下降的变化趋势.用扫描电镜观察,发现制备的载乙酸油酯微胶囊大小在5～8μm并且乙酸油酯以核壳式结构的形式被包覆在微胶囊内部.     

复凝聚法辣椒油树脂微胶囊的制备

以辣椒油树脂为芯材,明胶和阿拉伯胶为壁材,采用复凝聚法制得辣椒油树脂微胶囊.考察了45℃、体系浓度为5%时,pH值、乳化剂的用量、搅拌速度等几个因素对微胶囊形成的影响.     

大豆分离蛋白-十二烷基硫酸钠微胶囊的制备与表征

以大豆分离蛋白(SPI)和十二烷基硫酸钠(SDS)为壁材, 以十六烷为芯材, 通过复凝聚法制备了微胶囊. 首先确定了SPI和SDS发生复凝聚的适宜pH、SPI/SDS配比、壁材浓度等. 在确定的实验条件下进行复凝聚, 凝聚物产率可达85%. 改变搅拌转速和芯壁比, 考察它们对微胶囊性能的影响. 用光学显微镜观察了微胶囊形貌. 用气相色谱测定了微胶囊的载药量和包覆率. 芯壁比为2、搅拌转速为400 r/min时所制备微胶囊的载药量可达61%. 随着芯壁比的增大, 微胶囊粒径及载药量都逐渐增大.     

超声复凝聚法制备海藻酸钠-明胶-维生素B1纳米胶囊

采用超声复凝聚法制备了海藻酸钠-明胶-维生素B₁纳米胶囊。采用控制单因素变量法探讨了明胶浓度、海藻酸钠浓度、维生素B₁浓度、pH、固化时间、温度等因素对胶囊包封率的影响,并通过正交试验确定了制备纳米胶囊的最佳工艺条件为明胶浓度0.8%、海藻酸钠浓度0.8%、维生素B₁浓度2.5%、pH为4.2、固化时间15min、温度55℃。制备的纳米胶囊包封率为42.68%,载药量为31.27%。     

微乳中纳米胶囊的复凝聚法制备

在O/W型APG微乳液模板上, 以明胶和阿拉伯树胶作为包裹材料, 用复凝聚的方法制备纳米胶囊, 对影响纳米胶囊的合成条件进行了分析. 用粒度仪测定产物的粒径及其分布, 用透射电镜观察产物的形貌. 结果表明, 用复凝聚法在微乳中合成了粒度均匀、粒径30～100 nm的球性纳米胶囊. 考察了微乳液的组成、高分子的浓度和复凝聚的条件对纳米胶囊性质的影响. 纳米胶囊对氯氰菊酯的包裹率较高, 在60%以上. 本方法条件温和, 操作简单, 是一种新型的纳米胶囊合成技术.     

溶剂挥发法制备萃取剂微胶囊

萃取剂微胶囊的制备是利用微囊化方法将萃取剂包覆起来 ,解决传统液液萃取中的两相相分散、相混合、相分离以及溶剂的损失和设备结构复杂等问题 .用简单易控制的溶剂挥发法成功制备了聚砜及聚苯乙烯材料包覆的多种萃取剂 (如磷酸三丁酯 ,2 乙基己基磷酸 ,三辛胺和Aliquat 336 )微胶囊 ,并考察了壁材和分散剂的选择对不同萃取剂进行包覆的影响 ,同时研究了搅拌速度和膜溶液组成对微胶囊的形态、萃取剂包覆量的影响 .结果表明 ,(1)用聚砜作壁材可以包覆磷酸三丁酯、2 乙基己基磷酸 ,而用聚苯乙烯可以包覆三辛胺、Aliquat336 ;(2 )对于不同的O W乳液体系 ,只有选择合适的分散剂 ,才能得到理想球形状、分散性好的微胶囊 ;(3)增大搅拌速度可以降低液滴尺度 ,从而减小微胶囊粒径 ;(4)膜溶液组成的影响则表现在两个方面 ,一是膜溶液的粘度和两相界面张力是除搅拌速度外微胶囊粒径的决定因素 ,二是膜溶液中壁材与萃取剂的比例优化时 ,才能得到萃取剂包覆量高的微胶囊 .     

Microencapsulation of dodecyl acetate by complex coacervation of whey protein with acacia gum and its release behavior

Complex coacervation of whey protein(WP) with acacia gum(AG) was carried out in water with the presence of dodecyl acetate (DA),a component of insect sex pheromones,in order to obtain microcapsules with DA as the core material and WP-AG coacervate as the wall materials.Through variations in wall/core ratios,concentrations of the wall materials in capsule preparations,DA encapsulation was optimized,which showed a high DA encapsulation was achieved when coacervation was conducted at pH 3.5 with wall/core mass ratio at 3 combined with concentration of wall materials at 1.0 wt%.Morphology and the structure of DA loaded microcapsules were examined by scanning electron microscope,which showed the microcapsules were of core/shell structure with DA encapsulated in the inner of the microcapsules.DA release was examined and the behavior of the release was discussed.     

Soy glycinin microcapsules by simple coacervation method

Encapsulation of a dispersed oil phase (hexadecane) was realized by simple coacervation method using soy glycinin as the wall forming material. Suitable emulsification and coacervation conditions, that favor the formation of microcapsules wall, were identified and investigated. Mild acid (pH 2.0) and heat (55 degrees C) treatments of the reaction medium during the emulsification step enhanced significantly the deposition of coacervated glycinin around oil droplets. A pronounced correlation between glycinin concentration in the continuous phase, specific surface of the dispersed phase and the microencapsulation efficiency was also observed. Coacervation step study concerned the morphology and the stability of microcapsules. Controlled initiation of the coacervation, by slow readjustment of the pH, allowed a homogeneous precipitation of glycinin around oil droplets as well as the absence of aggregation phenomena. Since the morphology of microcapsules was considerably affected by a prolonged stirring of the reaction medium, the coacervation and reticulation time were optimized in order to preserve the homogeneity of the microcapsules size distribution and the microencapsulation efficiency.     

Microencapsulation of Fish Oil by Simple Coacervation of Hydroxypropyl Methylcellulose

To improve the oxidative stability and application of fish oil, it was microencapsulated by simple coacervation followed by spray drying. Simple coacervation took place by adding malt dextrin into the emulsion of fish oil and hydroxypropyl methylcellulose （HPMC） solution. Influences of several process parameters on the microencapsulation were evaluated and the oxidative stability and microstructure of microcapsules were analyzed. Results showed that the coacervation could be observed only when dextrose equivalent value （DE value） of malt dextrin, concentration of HPMC solution and fish oil percentage in microcapsules were no more than 20. 5% and 40%, respectively. Moreover, microencapsulation efficiency was higher at HPMC solution concentration of 4% and fish oil percentage of less than 30%. The oxidative stability of fish oil was improved by the microencapsulation and done best in the ease of replacing malt dextrin by 40% with acacia. Scanning electronic microscopic photographs showed that the microcapsule obtained was a round, smooth and hollow microcapsule with its wall made up of innumerable small and solid submicrocapsules with the core of fish oil.     

Preparation and properties of chitosan chondroitin sulfate complex microcapsules

The chitosan (CHS) chondroitin sulfate (CS) complex microcapsules were prepared by emulsion-chemical crosslink method, with the chitosan and chondroitin sulfate as the wall materials and the low molecular weight heparin (LMWH) as the core materials. The microcapsules were characterized by Fourier transform infrared (IR) spectrometry, scanning electron microscope (SEM), size distribution and thermal analysis. The in vitro drug release behavior of the microcapsules was studied by spectrophotometry. The SEM and size distribution showed that the microcapsules were in the spherical form mostly in the size range of 20-80 microm. The IR spectrum indicated that there were electrostatic interactions between chitosan and chondroitin sulfate, with the sulfate group and free carboxyl group reacted with the amino groups of chitosan. The DSC result showed that the wall materials could protect the core materials of the microcapsules. The results of the release kinetics experiments of the microcapsules showed that the drug released slightly faster in acid media than in alkali ones.     

Study of Complex Coacervation of Gelatin A and Sodium Alginate for Microencapsulation of Olive Oil

Complex coacervation of gelatin A and sodium alginate was carried out to obtain the maximum coacervate yield. Turbidity and coacervate yield (%) measurements were carried out to support the ratio of the two polymers and pH that produced maximum coacervation. The optimum ratio between gelatin A-sodium alginate and pH to form the maximum coacervate complex was found to be 3.5:1 and 3.5–3.8, respectively. Olive oil microencapsulation was carried out at the optimized ratio and pH. Microcapsules were crosslinked by using glutaraldehyde. Scanning electron microscopy studies confirmed the formation of free flowing spherical microcapsules of different sizes. The size of microcapsules increased with the increase in the concentration of the polymer. The encapsulation efficiency and the release rates of olive oil were dependent on the amount of crosslinker, oil loading and polymer concentration. Thermogravimetric study revealed improvement of thermal stability with crosslinking. Fourier Transform Infrared Spectroscopy study showed that there was no significant interaction between olive oil and gelatin-alginate complex.